· The applicant was first registered as an intern in New South Wales on 6 January 1997. After completing his internship his registration status became "General" with effect from 18 February 1998. In 2003 he became addicted to codeine. Following a hearing before the Impaired Registrants Panel the applicant agreed to conditions being placed on his registration effective from 4 August 2004. The applicant breached some of those conditions. The Health Care Complaints Commission (HCCC) initiated proceedings, by way of two complaints, before the Tribunal (March 2009 Tribunal). The first complaint alleged breaches of three of the conditions imposed upon the applicant as a result of the hearing before the Impaired Registrants Panel. The second complaint alleged that the applicant suffered from an impairment which detrimentally affects his capacity to practise medicine.
· The substance of the first complaint was that the applicant had self-administered a narcotic derivative non-prescription compound analgesic and/or cold medication on 17 occasions between 20 December 2004 and 28 September 2007. According to the March 2009 Tribunal Decision, the drugs detected were morphine trace and on two occasions, pseudoephedrine. It was also alleged, in further breach of conditions, that the applicant, who was required to attend for urine testing thrice-weekly, had provided dilute or very dilute samples on 72 occasions between December 2004 and September 2007 which rendered the tests invalid, and, had failed to forward test results for Carbohydrate Deficient Transferrin (CDT) levels between March 2007 and November 2007 to the Board's nominated psychiatrist.
· Before the March 2009 Tribunal, the applicant admitted he had breached the conditions. He attributed his conduct to anxiety and depression. He also said he had a poor attitude caused by negative thought processes and he resented having to conform to the conditions of his registration. A number of adverse findings were made against the applicant, including the finding that he had lied to persons in authority on several occasions over many years. Nevertheless, a number of findings were made in the applicant's favour. Some of those findings appear in the following extract from the March 2009 Tribunal Decision:
However the Tribunal has received evidence from Dr Wodak who was retained by the Health Care Complaints Commission. He is an expert in the treatment of alcohol and drug dependence. Dr Wodak is of the view that Mr Martin's prognosis is very positive based on the test results over the last 11 months and the descriptions given by Dr Martin's treating doctors.
Dr Pethebridge is the psychiatrist who has regularly reviewed Dr Martin for the Board since July 2004. He is a specialist in the rehabilitation of impaired doctors. He was of the view that the threat of suspension from practice precipitated the changes in Dr Martin's behaviour. Dr Pethebridge believes that Dr Martin's compliance over the past year is a good indication that he has a good prognosis. The regular consultations with his psychiatrist and psychologist have resulted in significant progress, in particular the cognitive behaviour therapy has assisted him to deal with his anxiety.
The Tribunal accordingly accepts that over the past 12 months Dr Martin has displayed a significant change in his behaviour and attitude. Over that year he has complied with the conditions on his registration and there is no evidence of his using any substance for which his urine has been tested.
· The HCCC had sought orders that the applicant's name be removed from the Register on the basis that his conduct was sufficiently serious to justify that course being taken. Instead, the Tribunal determined that it was appropriate that the applicant be reprimanded and his registration be the subject of conditions to ensure he obtained treatment and in order to monitor his compliance. The three conditions imposed by the Impaired Registrants Panel which the applicant breached were directed to be critical compliance conditions under s 61(3) of the Act. The effect of a direction of this type is that in the event of a finding by a Tribunal that an applicant has contravened a critical compliance condition, the Tribunal must order that the applicant be de-registered under s 64(1A) of the Act.
· On 13 May 2009, the Board conducted an interview with the applicant to review the conditions imposed by the March 2009 Tribunal. The report noted that the applicant is drinking no more than two standard drinks of alcohol every two to three weeks and that his CDT testing has remained within the normal range. It also noted that the applicant had been compliant with his conditions, achieving negative urinalysis results, and normal CDT results. It was recommended that no changes be made to the conditions.
· On 29 July 2009, the applicant's wife gave birth to their third child. Complications resulting from the birth required medical intervention. The applicant remained at the hospital throughout the day in order to be with his wife. On that day, the applicant was also scheduled to attend for urinary drug testing (UDT) and for an appointment with the Board-nominated psychiatrist, Dr Pethebridge, in accordance with his conditions. It was not until 7 August 2009 that the applicant notified the Board that he had failed to attend for the UDT on 29 July 2009. On 20 August 2009, the Board convened a s 66 Inquiry in order to determine whether the applicant had breached a critical compliance condition (relating to the failure to attend for the UDT). The Inquiry determined that the applicant had breached the condition by reason of his failure to attend for UDT on the required day, and, his failure to notify the Board immediately as required by the Protocol.
· These failures reflected a breach of Condition 10, one of the health condition imposed on the applicant by the March 2009 Tribunal. Condition 10 required the applicant:
10. a. To attend for thrice weekly Urine Drug Testing in strict accordance with the NSW Medical Board's protocol (a copy of which is included in the Participant's Handbook). Results of Urine Drug Testing to be forwarded to the Board-nominated and treating practitioners and to the NSW Medical Board. Such Urine Drug Testing to be at Dr Martin's expense.
b. If Dr Martin misses a test due to illness and seeks to provide an explanation pursuant to paragraph 3.5 of the NSW Medical Board's protocol, any accompanying medical certificate must be issued by his nominated treating general practitioner or one alternative general practitioner previously approved by the NSW Medical Board.
· The Board's Protocol for UDT contained the following relevant information:
2. Collection and Testing
Collection and testing must be in accordance with the Australian Standard and meet its chain of custody requirements. The New South Wales Medical Board has some requirements additional to those of the Australian Standard. The New South Wales Medical Board's provider of urine drug testing services is PaLMS (Pacific Laboratory Medicine Services) Toxicology Unit. Contact details for PaLMS Toxicology Unit can be found in the section titled Contact Details .
2.1 Collection
Doctors have three options in arranging supervised collection of urine samples:
(a) Supervised collection at a PaLMS collection facility. A list of locations is contained in the section titled PaLMS Collection Sites on page 28.
(b) Collection supervised by a supervisor approved by the Board, using postage paid collection kits provided by PaLMS to the approved supervisor. (Supervised collection guidelines can be found on page 27 in the section titled Supervised Collection Guidelines ). Kits can be obtained by contacting PaLMS on telephone (02) 9887 5666. You will be invoiced for the collection kits by PaLMS.
(c) Collection supervised by another pathology provider approved by the Board. Collection centres of PaLMS' competitors are often prepared to supervise collection, and forward the samples to PaLMS Toxicology Unit for testing. Most pathology providers will have collection kits that satisfy the Australian Standard.
2.2 Testing
In accordance with Australian AS/NZS 4308, drugs routinely tested for include cannabis, opiates (morphine and codeine), cocaine, amphetamine and benzodiazepines. In addition, specimens are tested for pethidine, barbiturates and tramadol. In certain cases, a doctor's conditions may require their urine samples be tested for additional drugs.
3. Testing Protocol
Doctors undertaking urine drug testing are expected to strictly comply with these requirements.
...
3.2 Thrice-Weekly Testing
· Testing is conducted on Monday, Wednesday, Friday of each week. It is not acceptable to present on other days in lieu of routine collection days without prior approval.